Episode

Episode 492: Novel Biomarkers and Targets in Germ Cell Tumors

Podcast: The Uromigos
Published: Apr 6, 2026
Duration seconds: 2005
Processing state: not_requested
Canonical source: https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-492-Novel-Biomarkers-and-Targets-in-Germ-Cell-Tumors-e3hb05a
Audio: https://anchor.fm/s/13347ea8/podcast/play/117849706/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-3-2%2F421267842-44100-2-8dc0ebe46d00f.m4a
JSON: /v1/public/podcasts/the-uromigos-1214845/episodes/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors
Markdown: /podcast/the-uromigos-1214845/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-uromigos-1214845/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

This podcast features Dr. Mike Glover from MDACC discussing recent advances in germ cell tumor research, focusing on novel biomarkers like microRNA and ctDNA, and emerging therapies targeting Claudin-6. The conversation explores how these innovations could transform diagnosis, prognosis, and treatment strategies.